Clinical Trials Directory

Trials / Terminated

TerminatedNCT03987672

Study to Intervene With Nutrition for Gastroparesis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study is a self-controlled study in which we will assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula in patients with gastroparesis, relative to their pre-enrollment nutritional diet regimen.

Detailed description

The study is a prospective self-controlled study in which we will assess the nutritional effects of Kate Farm Peptide 1.5 nutritional formula in patients with gastroparesis, relative to their pre-enrollment diet regimen. The duration of the study will be 12 weeks. We plan to recruit a total of 30 patients. Patients will undergo a baseline measurement of their height, weight, symptom burden, resting energy expenditure, inflammation, and microbiome. After study initiation, patient will undergo repeat testing at 1- and 3-months post-enrollment. Including the screening and baseline visits, there will be a total of 4 visits required to complete the study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAssess the nutritional effects of the Kate Farm Peptide 1.5 nutritional FormulaKate Farm Peptide 1.5 nutritional Formula

Timeline

Start date
2019-08-01
Primary completion
2022-08-18
Completion
2022-08-18
First posted
2019-06-17
Last updated
2022-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03987672. Inclusion in this directory is not an endorsement.